The Src inhibitor AZD0530 blocks invasion and may act as a radiosensitizer in lung cancer cells

With the emergence of Src inhibitors in clinical trials, improved knowledge of the molecular responses of cancer cells to these agents is warranted. This will facilitate the development of tests to identify patients who may benefit from these agents, allow drug activity to be monitored and rationali...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Purnell, P.R., Mack, P.C., Tepper, C.G., Evans, C.P., Green, T.P., Gumerlock, P.H., Lara, P.N., Gandara, D.R., Kung, H.J., Gautschi, O.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2009
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC2716757/
https://ncbi.nlm.nih.gov/pubmed/19240653
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JTO.0b013e31819c78fb
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg